Sudden Death in Competitive Athletes

Clinics in Sports Medicine

Volumn 27, Issue 1, 2008, Pages 153-181

  Pigozzi, Fabio ^a   Rizzo, Marta ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; ATHLETE; BRAIN ARTERY ANEURYSM; BRUGADA SYNDROME; CARDIOMYOPATHY; COMPETITION; CORONARY ARTERY DISEASE; DRUG ABUSE; ELECTROCARDIOGRAPHY; HEART DISEASE; HEART RIGHT VENTRICLE DYSPLASIA; HEAT STROKE; HUMAN; MARFAN SYNDROME; MYOCARDITIS; REVIEW; SICKLE CELL TRAIT; SUDDEN DEATH; TRAINING;

DEATH, SUDDEN; HEART DISEASES; HUMANS; MASS SCREENING; SPORTS;

EID: 38449106793     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2007.09.004     Document Type: Review

References (129)

1. Maron B.J., Epstein S.E., and Roberts W.C. Causes of sudden death in competitive athletes. J Am Coll Cardiol 7 (1986) 204-214
2. Maron B.J., Shirani J., Polia L.C., et al. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles. JAMA 276 (1996) 199-204
3. Maron B.J., Gohman T.E., and Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 32 (1998) 1881-1884
4. Corrado D., Basso C., Rizzoli G., et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 11 (2003) 1956-1963
5. Thompson P.D., Stern M.P., Williams P., et al. Incidence of death during jogging in Rhode Island from 1975 to 1980. JAMA 274 (1982) 2535-2538
6. Maron B.J., Poliac L.C., and Roberts W.C. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 28 (1996) 428-431
7. Corrado D., Pelliccia A., Bjornstad H.H., et al. Cardiovascular pre-participation screening for young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26 (2005) 516-524
8. Futterman L.G., and Myerburg R. Sudden death in athletes. An update. Sports Med 26 5 (1998) 335-350
9. Van Camp S.P., Bloor C.M., Mueller F.O., et al. Nontraumatic sports deaths in high school and college athletes. Med Sci Sports Exerc 27 (1995) 641-647
10. Corrado D., Basso C., Schiavon M., et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 (1998) 364-369
11. Towbin J.A. Molecular basis of sudden cardiac death. Cardiovasc pathol 10 (2001) 283-295
12. Maron B.J., Roberts W.C., McAllister H.A., et al. Sudden death in young athletes. Circulation 62 (1980) 218-229
13. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
14. Pelliccia A., Di Paolo F.M., Corrado D., et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 27 18 (2006) 2196-2200
15. Corrado D., Thiene G., Nava A., et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 89 (1990) 588-968
16. Basso C., Maron B.J., Corrado D., et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 35 6 (2000) 1493-1501
17. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
18. Watkins H., Thierfelder L., Hwang D.S., et al. Sporadic hypertrophy cardiomyopathy due to de novo myosin mutations. J Clin Invest 90 (1992) 1666-1671
19. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
20. Basilico F.C. Cardiovascular disease in athletes. Am J Sports Med 27 (1999) 108-121
21. Priori S.G., Aliot E., Blomstrom-Lundquist L., et al. Task force on Sudden Cardiac Death of the European Society of Cardiology. Europace 4 1 (2002) 3-18
22. Maron B.J., Roberts W.C., and Epstein S.E. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 65 (1982) 1188-1194
23. Maron B.J., Wolfoson J.K., Cirò E., et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 51 (1983) 189-194
24. Spirito P., Pelliccia A., Proschan M.A., et al. Morphology of "athlete's heart" assessed by echocardiography in 947 elite athletes, representing 27 sports. J Am Coll Cardiol 74 (1994) 802-869
25. Pelliccia A., Maron B.J., and Spataro A. The upper limit of physiologic cardiac hypertrophy in highly trained athletes. N Engl J Med 324 (1991) 295-301
26. Maron B.J., Pelliccia A., Spirito P., et al. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 91 (1995) 1956-16019
27. Pelliccia A., Maron B.J., Di Paolo F., et al. Prevalence and clinical significance of left atrial remodelling in competitive athletes. J Am Coll Cardiol 46 4 (2005) 690-696
28. Pelliccia A., Maron B.J., Culasso F., et al. Athlete's heart in women. Echocardiographic characterization of highly trained and elite female athletes. JAMA 276 (1996) 211-215
29. Pelliccia A., Maron B.J., Spataro A., et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 69 (1993) 125-128
30. Pelliccia A., Maron B.J., De Luca R., et al. Remodelling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 105 (2002) 944-949
31. Marian A.J., and Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 92 (1995) 1336-1347
32. Yang Z., Bowles N.E., Scherer S.E., et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) [Epub ahead of print]
33. MacRae C.A., Birchmeier W., and Thierfelder L. Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism. J Clin Invest 116 7 (2006) 1825-1828
34. Corrado D., Basso C., and Thiene G. Cardiomyopathy: arrhythmogenic ventricular cardiomyopathy: diagnosis, prognosis and treatment. Heart 83 (2000) 588-595
35. Cho Y., Park T., Yang D.H., et al. Arrhythmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans. Circ J 67 (2003) 925-928
36. Thiene G., Nava A., Corrado D., et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318 (1988) 129-133
37. McKenna W.J., Thiene G., and Nava A. Diagnosis of arrhythmogenic right ventricular dysplaisa/cardiomyopathy. Br Heart J 71 (1994) 215-218
38. Corrado D., Basso C., Buja G., et al. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 103 (2001) 710-711
39. Baran A., Nanda N.C., Falkoff M., et al. Two-dimensional echocardiography detection of arrhythmogenic ventricular dysplasia. Am Heart J 123 (1982) 711-724
40. Tandri H., Bomma C., Calkins H., et al. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 19 (2004) 848-858
41. Ahmad F. The molecular genetics of arrhythmogenic ventricular dysplasia-cardiomyopathy. Clin Invest Med 26 (2003) 167-178
42. Anderson E.L. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am Fam Physician 73 (2006) 1391-1398 1401
43. Roberts W.C., Siegel R.J., and Zipes D.P. Origin of the right coronary artery from the left sinus of Valsalva and its functional consequences: analysis of 10 necropsy patients. Am J Cardiol 49 (1982) 863-868
44. Maron B.J., and Liberthson R.R. Sudden death from cardiac causes in children and young adults. N Engl J Med 334 (1996) 1039-1044
45. Yamanaka O., and Hobbs R.E. Coronary artery anomalies in 12595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn 21 (1990) 28-40
46. Davis J.A., Cecchin F., Jones T.K., et al. Major coronary anomalies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol 37 (2001) 593-597
47. Pelliccia A., Spataro A., and Maron B.J. Prospective echocardiographic screening for coronary artery anomalies in 1360 elite competitive athletes. Am J Cardiol 72 (1993) 978-979
48. McConnell M.V., Ganz P., Selwyn A.P., et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 92 (1995) 3158-3162
49. Tilstra D.J., and Byers P.H. Molecular basis of hereditary disorders of connective tissue. Annu Rev Med 45 (1994) 149-163
50. Roman M.J., Rosen S.S., Kramer-Fox R., et al. The prognostic significance of the pattern of aortic root dilatation in the Marfan syndrome. J Am Coll Cardiol 22 (1993) 1470-1476
51. Marsalese D.L., Moodie D.S., Vacante M., et al. Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement. J Am Coll Cardiol 14 (1989) 422-428
52. Dingemans K.P., Teeling P., Van der Wal A.C., et al. Ultrastructural pathology of aortic dissections in patients with Marfan syndrome: comparison with dissections in patients without Marfan syndrome. Cardiovasc Pathol 15 4 (2006) 203-212
53. Pan C.W., Chen C.C., Wang S.P., et al. Echocardiographic study of cardiac abnormalities in families of patients with Marfan's syndrome. J Am Coll Cardiol 6 (1985) 1016-1020
54. Roman M.J., Devereux R.B., Kramer-Fox R., et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 64 (1989) 507-512
55. Asher C.R., and Lever H.M. Echocardiographic profiles of diseases associated with sudden cardiac death in young athletes. In: Williams R.A. (Ed). The athlete and heart disease: diagnosis and management (1999), Lippincott Williams & Wilkins, Philadelphia 155-172
56. Graham Jr. T.P., Bricker J.T., James F.W., et al. Task force 1: congenital heart disease. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task force 1: congenital heart disease. J Am Coll Cardiol 24 4 (1994) 867-873
57. Saeed I.M., and Braverman A.C. Approach to the athlete with thoracic aortic disease. Curr Sports Med Rep 6 2 (2007) 101-107
58. McDonald G.R., Schaff H.V., Pyeritz R.E., et al. Surgical management of patients with the Marfan syndrome and dilatation of the ascending aorta. J Thorac Cardiovasc Surg 81 (1981) 180-186
59. Glorioso Jr. J., and Reeves M. Marfan syndrome: screening for sudden death in athletes. Curr Sports Med Rep 1 2 (2002) 67-74
60. Kinoshita N., Mimura J., Obayashi C., et al. Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age. Am Heart J 139 4 (2000) 723-728
61. Kasikcioglu E. Aortic elastic properties with Marfanoid habitus: the need for early and accurate diagnostic methods. Eur Heart J 26 1 (2005) 100
62. Glover D.W., and Maron B.J. Profile of preparticipation cardiovascular screening for high school athletes. JAMA 279 (1998) 1817-1819
63. Bresler M.J. Acute pericarditis and myocarditis. Emerg Med 24 (1992) 35-41
64. Warner W.A. Cocaine abuse. Ann Intern Med 119 (1993) 226-235
65. Philips M., Robinowitz M., Higgins J.R., et al. Sudden cardiac death in Air Force recruits. JAMA 256 (1986) 2696-2699
66. Karalainen J., Nieminen M.S., and Heikkila J. Influenza A1 myocarditis in conscripts. Acta Med Scand 207 (1980) 27-30
67. Maron BJ, Isner JM, McKenna WJ. Task force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. In: Maron BJ, Mitchell JH, editors: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 1994; 24:880-885.
68. Chimenti C., Pieroni M., and Frustaci A. Myocarditis: when to suspect and how to diagnose it in athletes. J Cardiovasc Med (Hagerstown) 7 4 (2006) 301-306
69. Corrado D., Basso C., and Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50 2 (2001) 399-408
70. Koester M.C. A review of sudden cardiac death in young athletes and strategies for preparticipation screening. J Athl Train 36 2 (2001) 197-204
71. Manolio T.A., Baughman K.L., Rodeheffer R., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute Workshop). Am J Cardiol 69 (1992) 1458-1466
72. Tabib A., Miras A., Taniere P., et al. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. Eur Heart J 20 (1999) 900-903
73. Richardson P., McKenna W., Briston M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-842
74. Pelliccia A., Culasso F., Di Paolo F., et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130 (1999) 23-31
75. Freed L.A., Levy D., Levine R.A., et al. Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 34 (1999) 1-7
76. Zuppiroli A., Rinaldi M., Kramer-Fox R., et al. Natural history of mitral valve prolapse. Am J Cardiol 75 (1995) 1028-1032
77. Corrado D., Basso C., Nava A., et al. Sudden death in young people with apparently isolated MVP. G Ital Cardiol 27 (1997) 1097-1105
78. Kulan K., Komsuoglu B., Tunler C., et al. Significance of QT dispersion on ventricular arrhythmias in mitral valve prolapse. Int J Cardiol 54 (1996) 251-257
79. Digeos-Hasnier S., Copie X., Paziaud O., et al. Abnormalities of ventricular repolarization in mitral valve prolapse. Ann Noninvasive Electrocardiol 10 3 (2005) 297-304
80. Cheitlin M.D., Alpert J.S., Armstrong W.F., et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography. Circulation 95 (1997) 1686-1744
81. Burke A., Subramanian R., Virmani R., et al. Nonatherosclerotic narrowing of atrioventricular nodal artery and sudden death. J Am Coll Cardiol 21 (1993) 117-122
82. Thiene G., Pennelli N., and Rossi L. Cardiac conduction system abnormalities as a possible cause of sudden death in young athletes. Hum Pathol 14 (1983) 704-709
83. Corrado D., Basso C., and Thiene G. Is it time to include ion channel diseases among cardiomyopathies?. J Electrocardiol 38 4 Suppl (2005) 81-87
84. Arias M.A., Fernandez-Guerrero J.C., Herrador J., et al. Catecholaminergic polymorphic ventricular tachycardia as a cause of sudden death in athletes. Am J Emerg Med 24 2 (2006) 253-254
85. Seidman C. Cardiovascular genetic disorders that cause sudden death in athletes. In: William R.A. (Ed). The athlete and heart disease: diagnosis and management (1999), Lippincott Williams & Wilkins, Philadelphia 41-52
86. Ackeman M.J. The long QT syndrome. Pediatr Rev 19 (1998) 232-238
87. Moss A.J., and Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation 85 I (1992) 140-144
88. Napolitano C., Bloise R., and Priori S.G. Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sports activity. J Cardiovasc Med 7 4 (2006) 250-256
89. Merri M., Benhorin J., Alberti M., et al. Electrocardiographic quantification of ventricular repolarization. Circulation 80 (1989) 1301-1308
90. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in the long QT syndrome. N Engl J Med 348 (2003) 1866-1874
91. Schwartz P.J., Priori S.G., and Napolitano C. The Long QT syndrome. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside. Third edition (2000), WB Saunders, Philadelphia 788-811
92. Franklin BA, Roitman L. Cardiorespiratory adaptations to exercise. In: ACSM's resource manual for guidelines for exercise testing and prescription. Third edition. Philadelphia: Lippincott Williams & Wilkins. p. 156-63.
93. Waller B.F., and Roberts W.C. Sudden death while running in conditioned runners aged 40 years or over. Am J Cardiol 45 (1980) 1292-1300
94. Northcote R.J., Evans A.D.B., and Ballantyne D. Sudden death in squash players. Lancet 1 (1984) 148-151
95. Noakes T. Heart disease in marathon runners: a review. Med Sci Sports Exerc 19 (1987) 187-194
96. Jackson R.T., Beaglehole N.R., and Sharpe N. Sudden death in runners. N Z Med J 96 (1983) 289-292
97. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: structure, function and time-dependence of risk. Circulation 85 I (1992) 2-10
98. Maron B.J. Sudden cardiac death due to hypertrophic cardiomyopathy in young athletes. In: Williams R.A. (Ed). The athlete and heart disease: diagnosis and management (1999), Lippincott Williams & Wilkins, Philadelphia
99. Basso C., Thiene G., Corrado D., et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31 8 (2000) 893-894
100. Bennet P.B., Yazawa K., Makita N., et al. Molecular mechanisms for an inherited cardiac arrhythmia. Nature 376 (1995) 683-685
101. Taylor A.J., Rogan K.M., and Virmani R. Sudden cardiac death associated with congenital coronary anomalies. J Am Coll Cardiol 20 (1992) 640-647
102. Pelliccia A. Congenital coronary artery anomalies in young patients. New perspectives for timely identification. J Am Coll Cardiol 37 (2001) 598-600
103. Liberthson R.R., Dinsmore R.E., and Fallon J.T. Aberrant coronary artery origin from the aorta. Report of 18 patients, review of the literature and delineation of the natural history and management. Circulation 59 (1979) 748-754
104. Yetman A.T., Bornemeier R.A., and McCrindle B.W. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?. J Am Coll Cardiol 41 2 (2003) 329-332
105. Kerber R.C., Becker L.B., Bourland J.D., et al. Automatic external defibrillators for public access defibrillation: recommendations for specifying and reporting arrhythmia analysis algorithm performance, incorporating new waveforms, and enhancing safety. Circulation 95 (1997) 177-182
106. Maron B.J. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 129 (1998) 379-386
107. Drezner J.A., and Rogers K.J. Sudden cardiac arrest in intercollegiate athletes: detailed analysis and outcomes of resuscitation in nine cases. Heart Rhythm 3 7 (2006) 755-759 [Epub 2006 Mar 28]
108. Maron B.J., Thompson P.D., Puffer J.C., et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 94 (1996) 850-856
109. Cardiologic protocols for competitive sport's qualification of the Italian Committee for the competitive sport's qualification. Comitato organizzativo per l'idoneità allo sport (FMSI, SIC-Sport, SIC, ANCE, AMCO), et al. Protocolli cardiologici per il giudizio di idoneità allo sport agonistico. [in Italian]. G Ital Cardiol 19 (1989) 250-272
110. Pigozzi F., Spataro A., Fagnani F., et al. Preparticipation screening for the detection of cardiovascular abnormalities that may cause sudden death in competitive athletes. Br J Sports Med 37 1 (2003) 4-5
111. Pelliccia A., and Maron B.J. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol 75 (1995) 827-829
112. Lictman J., O'Rourke R.A., Klein A., et al. Electrocardiogram of the athlete: alterations simulating those of organic heart disease. Arch Intern Med 132 (1973) 763-770
113. Pelliccia A., Maron B.J., Culasso F., et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 102 (2000) 278-284
114. Pelliccia A., Fagard R., Bjornstad H.H., et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. A consensus document from the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26 14 (2005) 1422-1445
115. Maron B.J., Araùjo C.G., Thompson P.D., et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in master athletes. An advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation and Prevention. Circulation 103 (2001) 327-334
116. Rautaharju P.M., Prineas R.J., Eifler W.J., et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: multiple risk factor intervention trial experience. J Am Coll Cardiol 8 (1986) 1-10
117. Gibbons R.J., Balady G.J., Beasley J.W., et al. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 30 (1997) 260-311
118. Pigozzi F., Spataro A., Alabisio A., et al. Role of exercise stress test in master athletes. Br J Sports Med 39 (2005) 527-531
119. Maron B.J., Poliac L.C., Kaplan J.A., et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 333 (1995) 337-342
120. Weinstock J., Maron B.J., Song C., et al. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 117 4 (2006) 656-662
121. Stasburger J.F., and Maron B.J. Commotio cordis. N Engl J Med 347 (2002) 1248
122. Maron B.J., Gohman T.E., Kyle S.B., et al. Clinical profile and spectrum of commotio cordis. JAMA 287 (2002) 1142-1146
123. Link M.S., Maron B.J., VanderBrink B.A., et al. Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol 37 (2001) 649-654
124. Coris E.E., Ramirez A.M., and Van Durme D.J. Heat illness in athletes: the dangerous combination of heat, humidity and exercise. Sports Med 34 1 (2004) 9-16
125. Carter III R., Cheuvront S.N., Williams J.O., et al. Epidemiology of hospitalizations and deaths from heat illness in soldiers. Med Sci Sports Exerc 37 8 (2005) 1338-1344
126. Binkley H.M., Beckett J., Casa D.J., et al. National Athletic Trainer's Association position statement: exertional heat illness. J Athl Train 37 3 (2002) 329-343
127. Francis K., Feinstein R., and Brasher J. Heat illness in football players in Alabama. Ala Med 60 9 (1991) 10-14
128. Deligiannis A., Bjornstad H., Carre F., et al. ESC Study Group of Sports Cardiology position paper on cardiovascular adverse effects of doping in athletes. Eur J of Card Prev and Rehab 13 5 (2006) 687-694
129. Samenuk D., Link M.S., Homoud M.K., et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 77 (2002) 12-16